TriangleHEALTH PROFESSIONAL · SOURCE READING
Reduced-intensity therapy, including targeted therapy
Source: Acute Myeloid Leukemia Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: March 14, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Refractory or Recurrent AML / Chemotherapy
Patients who are unable or unwilling to undergo intensive therapy can be treated with reduced-intensity therapies.
Continue within this section
Preserved source evidence · Not medical advice